Market Overview

Hearing UBS Says Endo Likely to be Sold at $40+/share.

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ENDP

DateFirmActionFromTo
Oct 2014Cantor FitzgeraldUpgradesSellHold
Sep 2014RBC CapitalInitiates Coverage onOutperform
Jul 2014Cantor FitzgeraldMaintainsSell

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: UBSAnalyst Color News Rumors M&A Analyst Ratings Movers

 

Related Articles (ENDP)

Around the Web, We're Loving...

Get Benzinga's Newsletters